FDA Brief

Warning letters Biologics

FDA warning letter to

Celularity, Inc

Issued Dec 1, 2025Posted Dec 9, 2025Office of Compliance and Biologics Quality

Unapproved New Drug/Unlicensed Biological Product/Biologics License Application (BLA). We haven't summarized this letter yet. Read it on fda.gov.